XTSX
MDX
Market cap15mUSD
Oct 20, Last price
0.12CAD
Name
Medx Health Corp
Chart & performance
P/E
—
P/S
47.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
12.22%
Rev. gr., 5y
-2.26%
Revenues
473k
-3.43%
Net income
-6m
L+72.06%
CFO
-4m
L+48.44%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MedX Health Corp. develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It offers SIAscopy on DermSecure telemedicine platform, which is used to scan skin for suspicious moles and lesions, and phototherapeutic medical devices. Its brands include the DermSecure, MoleMate, SIMSYS, and SIAMETRICS. The company was founded on April 15, 1999 and is headquartered in Mississauga, Canada.
Key people
Scott Spearn
President, Chief Executive Officer, Director · since 2018
Jim Cooke
Chief Financial Officer · since 2013
Louie Canitano
Chief Operating Officer · since 2013
Steven T. Guillen
Director · since 2016
N. Gary Van Nest
Director · since 2018
Chairman of the Board · since 2018
Independent Director · since 2001
Kenneth McKay
Independent Director · since 2001
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||